Optimising neonatal intensive care
Neonatal intensive care specialises in the treatment of newborns, both preterm neonates and any newborn with a medical condition. [1-4]
Due to the fragile nature of neonates, monitoring, diagnosing and treating them can be challenging.
The NeoOne solution aims to support you in making diagnostic decisions, in taking care of neonates in the NICU and in improving outcomes.
The Neonatal Intensive Care Unit
The Neonatal Intensive Care Unit (NICU) specialises in treating neonates born premature or neonates that need extra care. These neonates present a range of critical conditions that caregivers need to diagnose, treat and monitor.
The care that neonates receive in the first hours and days can have a significant impact on their quality of life.
In the short term, the recognition and treatment of critical symptoms can save the neonate’s life. In the long term, when caregivers provide correct and timely treatment and avoid life-altering complications, this helps contribute to better quality of life.
NeoOne solution for neonatal care
In caring for fragile neonates blood gas results and continuous monitoring of oxygen and carbon dioxide are valuable.
The NeoOne solution empowers you to make well-informed treatment decisions in the NICU.
The NeoOne solution combines blood gas testing on a very small blood sample and continuous non-invasive monitoring of oxygen and carbon dioxide levels.
Blood gas testing in the NICU
Blood gas analysis provides information on a critically ill neonate’s respiratory and metabolic status, via insights to oxygen, carbon dioxide and the acid-base status, along with other vital information such as electrolytes, lactate, hemoglobin and bilirubin.
The ABL90 FLEX PLUS blood gas analyser provides 17 critical parameters from a sample as small as 45 microliters when using the blood-conserving MicroMode measurement dedicated for the NICU.
Collecting blood samples in the NICU
Blood samples as little as 45 microliters can be collected using the safeCLINITUBES capillary tubes.
The unique surface treatment of the safeCLINITUBES capillary tubes allows fast filling, making sampling procedures easier for clinicians and less stressful for neonates. All our capillary tubes are preheparinised with dry electrolyte-balanced heparin.
The safeCLINITUBES capillary tubes are also made of plastic, eliminating the risk of breakage and injury.
Transcutaneous monitoring in the NICU
Transcutaneous monitoring in the NICU provides a real-time continuous overview of the patient’s often fluctuating oxygenation (tcpO2) and ventilation (tcpCO2) status.
Transcutaneous monitoring is a non-invasive method where a sensor is applied to the skin and continuously measures blood gases diffusing through the skin.
Our TCM5 FLEX transcutaneous monitor has a dedicated NICU mode which automatically controls the sensor temperature and how long the sensor has been applied to the skin.
Combining blood gas testing and transcutaneous monitoring for better outcomes in the neonatal intensive care unit
October 8, 2015
Webinar presented by Dr. Kaare E. Lundstrøm, Pediatric emergency and intensive care unit, Rigshospitalet, Denmark
1. Ancel PY, et al. Survival and morbidity of preterm children born at 22 through 34 weeks' gestation in France in 2011: results of the EPIPAGE-2 cohort study. JAMA Pediatr. 2015; 169, 3: 230-238.
2. Marlow N, et al. EPICure Study Group. Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med. 2005; 352, 1: 9-19.
3. Johnson S, et al. Neurodevelopmental outcomes following late and moderate prematurity: a population-based cohort study. Arch Dis Child Fetal Neonatal Ed. Arch Dis Child Fetal Neonatal Ed. 2015; 100,
4: 301-308. 4. Fanaroff AA, et al. NICHD Neonatal Research Network. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol. 2007; 196, 2: 147.e